We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $434M
1-Year Est. Return 19.64%
This Fund
S&P 500
This Quarter Est. Return
+15.35%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$378M
AUM Growth
-$14.3M
Cap. Flow
-$37.7M
Cap. Flow %
-9.99%
Top 10 Hldgs %
14.76%
Holding
326
New
67
Increased
40
Reduced
57
Closed
66

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 17.8%
3 Healthcare 17.74%
4 Materials 11.05%
5 Communication Services 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
D icon
226
Dominion Energy
D
$59.3B
$395K 0.1%
5,000
ORGO icon
227
Organogenesis Holdings
ORGO
$239M
$384K 0.1%
100,000
-100,000
-50% -$395K
PNW icon
228
Pinnacle West Capital
PNW
$12.2B
$373K 0.1%
5,000
CDE icon
229
Coeur Mining
CDE
$17.9B
$369K 0.1%
50,000
+25,000
+100% +$188K
BIOC
230
DELISTED
Biocept, Inc.
BIOC
$368K 0.1%
+2,783
New +$562K
IMGN
231
DELISTED
Immunogen Inc
IMGN
$367K 0.1%
102,000
+2,000
+2% +$8.07K
HP icon
232
Helmerich & Payne
HP
$3.71B
$366K 0.1%
25,000
OTTR icon
233
Otter Tail
OTTR
$3.94B
$362K 0.1%
10,000
TTOO
234
DELISTED
T2 Biosystems, Inc
TTOO
$350K 0.09%
+52
New +$385K
AVA icon
235
Avista
AVA
$3.24B
$341K 0.09%
10,000
VNDA icon
236
Vanda Pharmaceuticals
VNDA
$302M
$338K 0.09%
+35,000
New +$374K
HE icon
237
Hawaiian Electric Industries
HE
$2.14B
$332K 0.09%
10,000
NS
238
DELISTED
NuStar Energy L.P.
NS
$329K 0.09%
31,000
SUPN icon
239
Supernus Pharmaceuticals
SUPN
$2.77B
$313K 0.08%
15,000
NPTN
240
DELISTED
NEOPHOTONICS CORP
NPTN
$311K 0.08%
+51,000
New +$389K
PULM icon
241
Pulmatrix
PULM
$6.06M
$298K 0.08%
12,500
+2,500
+25% +$63.7K
AL
242
DELISTED
Air Lease Corp
AL
$294K 0.08%
10,000
DBI icon
243
Designer Brands
DBI
$333M
$271K 0.07%
50,000
ECOR icon
244
electroCore
ECOR
$72.9M
$265K 0.07%
+10,210
New +$257K
WYY icon
245
WidePoint Corp
WYY
$114M
$255K 0.07%
+51,000
New +$324K
ADMA icon
246
ADMA Biologics
ADMA
$2.22B
$239K 0.06%
+100,000
New +$274K
MSFT icon
247
Microsoft
MSFT
$3.71T
$231K 0.06%
1,100
DTE icon
248
DTE Energy
DTE
$29.1B
$230K 0.06%
2,350
PBF icon
249
PBF Energy
PBF
$7.31B
$199K 0.05%
35,000
RNAC icon
250
Cartesian Therapeutics
RNAC
$268M
$186K 0.05%
2,500

Similar funds

Hussman Strategic Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Hussman Strategic Advisors held 326 positions worth $378M, down 3.6% from $392M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Hussman Strategic Advisors withdrew a net $37.7M in Q3 2020, closing 66 positions and reducing 57 holdings. Its most notable exit was Genpact, an estimated $2.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Hussman Strategic Advisors opened a new position in United Therapeutics worth $2.58M.

  • Hussman Strategic Advisors's largest Q3 2020 buy was United Therapeutics: 25,500 shares worth $2.58M.
  • Hussman Strategic Advisors added most to Alphabet (Google) Class C in Q3 2020, an estimated $3.89M increase.
  • Hussman Strategic Advisors's biggest Q3 2020 reduction was Newmont, cutting an estimated $6.18M.
  • Hussman Strategic Advisors fully exited Genpact in Q3 2020, selling an estimated $2.8M.
  • Hussman Strategic Advisors's ten largest holdings make up 15% of its $378M portfolio in Q3 2020.
  • Hussman Strategic Advisors opened 67 new positions and closed 66 in Q3 2020.
  • Hussman Strategic Advisors's portfolio value fell 3.6% quarter-over-quarter to $378M.

Based on Hussman Strategic Advisors's 13F filing for Q3 2020, filed 2 Nov 2020.